Literature DB >> 29196316

Restoring Serotonergic Homeostasis in the Lateral Hypothalamus Rescues Sleep Disturbances Induced by Early-Life Obesity.

Mary Gazea1, Alexandre V Patchev1, Elmira Anderzhanova1,2, Este Leidmaa1, Anna Pissioti1, Cornelia Flachskamm1, Osborne F X Almeida1, Mayumi Kimura3.   

Abstract

Early-life obesity predisposes to obesity in adulthood, a condition with broad medical implications including sleep disorders, which can exacerbate metabolic disturbances and disrupt cognitive and affective behaviors. In this study, we examined the long-term impact of transient peripubertal diet-induced obesity (ppDIO, induced between 4 and 10 weeks of age) on sleep-wake behavior in male mice. EEG and EMG recordings revealed that ppDIO increases sleep during the active phase but reduces resting-phase sleep quality. This impaired sleep phenotype persisted for up to 1 year, although animals were returned to a non-obesiogenic diet from postnatal week 11 onwards. To better understand the mechanisms responsible for the ppDIO-induced alterations in sleep, we focused on the lateral hypothalamus (LH). Mice exposed to ppDIO did not show altered mRNA expression levels of orexin and melanin-concentrating hormone, two peptides that are important for sleep-wake behavior and food intake. Conversely, the LH of ppDIO-exposed mice had reduced contents of serotonin (5-hydroxytryptamine, 5-HT), a neurotransmitter involved in both sleep-wake and satiety regulation. Interestingly, an acute peripheral injection of the satiety-signaling peptide YY 3-36 increased 5-HT turnover in the LH and ameliorated the ppDIO-induced sleep disturbances, suggesting the therapeutic potential of this peptide. These findings provide new insights into how sleep-wake behavior is programmed during early life and how peripheral and central signals are integrated to coordinate sleep.SIGNIFICANCE STATEMENT Adult physiology and behavior are strongly influenced by dynamic reorganization of the brain during puberty. The present work shows that obesity during puberty leads to persistently dysregulated patterns of sleep and wakefulness by blunting serotonergic signaling in the lateral hypothalamus. It also shows that pharmacological mimicry of satiety with peptide YY3-36 can reverse this neurochemical imbalance and acutely restore sleep composition. These findings add insight into how innate behaviors such as feeding and sleep are integrated and suggest a novel mechanism through which diet-induced obesity during puberty imposes its long-lasting effects on sleep-wake behavior.
Copyright © 2018 the authors 0270-6474/18/380441-11$15.00/0.

Entities:  

Keywords:  PYY; mice; obesity; puberty; serotonin; sleep disorders

Mesh:

Substances:

Year:  2017        PMID: 29196316      PMCID: PMC6596113          DOI: 10.1523/JNEUROSCI.1333-17.2017

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  82 in total

Review 1.  Central nervous system control of food intake.

Authors:  M W Schwartz; S C Woods; D Porte; R J Seeley; D G Baskin
Journal:  Nature       Date:  2000-04-06       Impact factor: 49.962

Review 2.  The adolescent brain and age-related behavioral manifestations.

Authors:  L P Spear
Journal:  Neurosci Biobehav Rev       Date:  2000-06       Impact factor: 8.989

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area.

Authors:  C F Elias; C Aschkenasi; C Lee; J Kelly; R S Ahima; C Bjorbaek; J S Flier; C B Saper; J K Elmquist
Journal:  Neuron       Date:  1999-08       Impact factor: 17.173

5.  Gut hormone PYY(3-36) physiologically inhibits food intake.

Authors:  Rachel L Batterham; Michael A Cowley; Caroline J Small; Herbert Herzog; Mark A Cohen; Catherine L Dakin; Alison M Wren; Audrey E Brynes; Malcolm J Low; Mohammad A Ghatei; Roger D Cone; Stephen R Bloom
Journal:  Nature       Date:  2002-08-08       Impact factor: 49.962

6.  Regulation of orexin neurons by the monoaminergic and cholinergic systems.

Authors:  Akihiro Yamanaka; Yo Muraki; Natsuko Tsujino; Katsutoshi Goto; Takeshi Sakurai
Journal:  Biochem Biophys Res Commun       Date:  2003-03-28       Impact factor: 3.575

7.  Novel generation of hormone receptor specificity by amino terminal processing of peptide YY.

Authors:  D Grandt; S Teyssen; M Schimiczek; J R Reeve; F Feth; W Rascher; H Hirche; M V Singer; P Layer; H Goebell
Journal:  Biochem Biophys Res Commun       Date:  1992-08-14       Impact factor: 3.575

8.  Characterization of blood-brain barrier permeability to PYY3-36 in the mouse.

Authors:  Naoko Nonaka; Seiji Shioda; Michael L Niehoff; William A Banks
Journal:  J Pharmacol Exp Ther       Date:  2003-05-15       Impact factor: 4.030

9.  Inhibition of food intake in obese subjects by peptide YY3-36.

Authors:  Rachel L Batterham; Mark A Cohen; Sandra M Ellis; Carel W Le Roux; Dominic J Withers; Gary S Frost; Mohammad A Ghatei; Stephen R Bloom
Journal:  N Engl J Med       Date:  2003-09-04       Impact factor: 91.245

10.  Hypothalamic orexin neurons regulate arousal according to energy balance in mice.

Authors:  Akihiro Yamanaka; Carsten T Beuckmann; Jon T Willie; Junko Hara; Natsuko Tsujino; Michihiro Mieda; Makoto Tominaga; Ken ichi Yagami; Fumihiro Sugiyama; Katsutoshi Goto; Masashi Yanagisawa; Takeshi Sakurai
Journal:  Neuron       Date:  2003-06-05       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.